ArticleOncotarget2017

Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types.

Jae-Ho Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.